DocGo (NASDAQ:DCGO) Receives “Buy” Rating from Needham & Company LLC

DocGo (NASDAQ:DCGO)‘s stock had its “buy” rating reiterated by Needham & Company LLC in a research report issued to clients and investors on Thursday,Benzinga reports. They presently have a $7.00 price objective on the stock. Needham & Company LLC’s target price would indicate a potential upside of 67.46% from the company’s previous close.

Separately, Cantor Fitzgerald reiterated an “overweight” rating and set a $5.00 price objective on shares of DocGo in a research note on Friday, September 20th. Five analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $6.10.

DocGo Trading Up 2.2 %

DocGo stock opened at $4.18 on Thursday. DocGo has a 52 week low of $2.75 and a 52 week high of $4.86. The stock has a market cap of $426.57 million, a P/E ratio of 14.93, a price-to-earnings-growth ratio of 11.49 and a beta of 0.97. The stock has a 50 day moving average of $4.21 and a 200-day moving average of $3.68.

Insider Transactions at DocGo

In related news, General Counsel Ely D. Tendler sold 23,088 shares of the firm’s stock in a transaction on Monday, December 16th. The stock was sold at an average price of $4.44, for a total transaction of $102,510.72. Following the transaction, the general counsel now directly owns 175,645 shares in the company, valued at $779,863.80. This trade represents a 11.62 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 2.70% of the company’s stock.

Institutional Trading of DocGo

Several institutional investors have recently added to or reduced their stakes in DCGO. Marathon Capital Management lifted its position in shares of DocGo by 2.3% in the 2nd quarter. Marathon Capital Management now owns 277,100 shares of the company’s stock worth $856,000 after buying an additional 6,285 shares during the last quarter. The Manufacturers Life Insurance Company raised its stake in DocGo by 31.6% during the second quarter. The Manufacturers Life Insurance Company now owns 40,401 shares of the company’s stock worth $125,000 after acquiring an additional 9,696 shares during the period. Centiva Capital LP bought a new position in DocGo in the third quarter worth about $43,000. Victory Capital Management Inc. boosted its stake in DocGo by 124.0% in the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock valued at $79,000 after acquiring an additional 14,191 shares during the period. Finally, WCM Investment Management LLC grew its holdings in shares of DocGo by 0.6% during the third quarter. WCM Investment Management LLC now owns 2,626,971 shares of the company’s stock valued at $8,879,000 after purchasing an additional 15,933 shares during the last quarter. Institutional investors own 56.44% of the company’s stock.

DocGo Company Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.